ArticleProstate cancer and prostatic diseases2024

Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study.

Yan Hiu Athena Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.